We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The company declared that set regulatory guidelines of Informed Consent Declaration, Insurance Terms and EC approvals will be followed to conduct the Multi-centric, Phase III clinical trials.